The synopsis for this grant opportunity is detailed below, following
this paragraph. This synopsis contains all of the updates to this
document that have been posted as of
02/05/2013
. If
updates have been made to the opportunity synopsis, update information
is provided below the synopsis.
If you would like to receive notifications of changes to the grant
opportunity click
send
me change notification emails
.
The only thing you need to provide for this service is your email
address. No other information is requested.
Any inconsistency between the original printed document and the disk
or electronic document shall be resolved by giving precedence to the
printed document.
Description of Modification
Please see Full Announcement Tab of the Program Announcement for the revised Attachment 1 - Biosketch Form revised 4-12-13.
Document Type:
Modification to Previous
Grants Notice
Funding Opportunity Number:
W81XWH-13-MOMJPC5-IPPEHA
Opportunity Category:
Discretionary
Posted Date:
Feb 05, 2013
Creation Date:
Apr 12, 2013
Original Closing Date for Applications:
May 14, 2013
Revised PA attached to extend deadlines to the following:
Invitation to Submit a Full Application: 28 MAR 2013;
Full Application Submission Deadline: 5:00 pm EST, 14 MAY 2013;
Scientific Peer Review: June 2013;
Programmatic Review: July 2013;
Funding/Not Funding Notification Letters: July 2013
Current Closing Date for Applications:
May 14, 2013
Revised PA attached to extend deadlines to the following:
Invitation to Submit a Full Application: 28 MAR 2013;
Full Application Submission Deadline: 5:00 pm EST, 14 MAY 2013;
Scientific Peer Review: June 2013;
Programmatic Review: July 2013;
Funding/Not Funding Notification Letters: July 2013
Archive Date:
May 26, 2013
Funding Instrument Type:
Cooperative Agreement
Grant
Category of Funding Activity:
Science and Technology and other Research and Development
Category Explanation:
Expected Number of Awards:
5
Estimated Total Program Funding:
$6,000,000
Award Ceiling:
Award Floor:
CFDA Number(s):
12.420
--
Military Medical Research and Development
Cost Sharing or Matching Requirement:
No
Eligible Applicants
Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"
Additional Information on Eligibility:
Agency Name
Dept. of the Army -- USAMRAA
Description
The DMRDP, IPPEHA expects to fund between three (3) and five (5) applications in response to this solicitation, depending on the quality and number of applications received and the total cost of applications approved for funding. Funding of applications received in response to this Program Announcement/Funding Opportunity is contingent upon the availability of Federal funds for this Program. An estimated $6M in FY13 funds are available to fund the first year of performance of successful proposals. Adequate funds to support the remaining years of performance are expected to become available through the DMRDP in future years. The Government reserves the right to increase or decrease the approximately $6M available to support awards.This Program Announcement/Funding Opportunity is focused on specific research topics of injury prevention, physiological health, and environmental health and protection as outlined in Section B. Investigators must demonstrate logical reasoning and a sound scientific rationale established through a critical review and analysis of the literature for the proposal to be competitive. Research projects should include a well-formulated, testable hypothesis based on a strong scientific rationale. This award mechanism is focused on applied research, defined as research that refines concepts and ideas into potential solutions to military health and performance problems with a view toward evaluating technical feasibility; includes studies and investigations leading to candidate solutions in preparation for initial human testing. This award mechanism will also support advanced technology development which is defined as research for the development of candidate solutions and components of early prototype systems for test and evaluation. Promising drug and vaccine candidates and medical devices and technologies are selected for initial safety and efficacy testing in small scale human clinical trials. Applications may include phase I or early phase II clinical trials, but not late phase II large-scale effectiveness clinical trials or advanced development of products and capabilities. Preliminary data are required for applied research and advanced technology development applications. Awards may not be used to support fundamental basic research, defined as research directed toward attaining a greater knowledge and understanding of fundamental principles of science and medicine relevant to the improvement of medical care in operationally relevant environments.A clinical trial is defined as a prospective accrual of human subjects where an intervention (e.g., device, drug, biologic, surgical procedure, rehabilitative modality, behavioral intervention or other) is tested on a human subject for a measurable outcome with respect to exploratory information, safety, effectiveness, and/or efficacy. This outcome represents a direct effect on the human subject of that intervention or interaction.
Link to Additional Information
If you have difficulty accessing the full announcement
electronically, please contact:
The following files represent the modifications to this synopsis
with the changes noted within the documents. The list of files is
arranged from newest to oldest with the newest file representing the
current synopsis. Changed sections from the previous document are shown
in a light grey background.
